KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Tax Assets Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Land & Improvements Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Other Preferred Equity Payables Preferred Shares Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

Teva Pharmaceutical Industries (TEVA) Pension: 2009-2017

Historic Pension for Teva Pharmaceutical Industries (TEVA) over the last 4 years, with Sep 2017 value amounting to $718.0 million.

Teva Pharmaceutical Industries' Pension was N/A to $718.0 million in Q3 2017 from the same period last year, while for Sep 2017 it was $718.0 million, marking a year-over-year change of. This contributed to the annual value of $859.0 million for FY2016, which is N/A change from last year.
Per Teva Pharmaceutical Industries' latest filing, its Pension stood at $718.0 million for Q3 2017, which was up 0.84% from $712.0 million recorded in Q2 2017.
Teva Pharmaceutical Industries' 5-year Pension high stood at $859.0 million for Q4 2016, and its period low was $660.0 million during Q1 2017.
Moreover, its 2-year median value for Pension was $715.0 million (2017), whereas its average is $737.2 million.